Variant report

Variant	rs6706874
Chromosome Location	chr2:113030205-113030206
allele	C/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:18)
CpG islands
(count:0)
Chromatin interactive
region (count:2)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:18 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:113030045-113030666	K562	blood:	n/a	n/a
2	JUND	chr2:113029639-113031158	K562	blood:	n/a	n/a
3	CUX1	chr2:113030202-113030856	K562	blood:	n/a	n/a
4	CEBPD	chr2:113030134-113030770	K562	blood:	n/a	n/a
5	TEAD4	chr2:113030107-113030833	K562	blood:	n/a	n/a
6	CEBPD	chr2:113030135-113030715	K562	blood:	n/a	n/a
7	TBL1XR1	chr2:113030047-113030862	K562	blood:	n/a	n/a
8	PML	chr2:113030155-113030672	K562	blood:	n/a	n/a
9	GATA1	chr2:113029747-113031594	K562	blood:	n/a	n/a
10	IRF1	chr2:113029973-113031927	K562	blood:	n/a	n/a
11	POLR2A	chr2:113030196-113032194	K562	blood:	n/a	n/a
12	GATA2	chr2:113030202-113030654	K562	blood:	n/a	n/a
13	EP300	chr2:113030096-113030770	K562	blood:	n/a	n/a
14	POLR2A	chr2:113030118-113030387	K562	blood:	n/a	n/a
15	NR2F2	chr2:113030194-113030657	K562	blood:	n/a	n/a
16	GATA1	chr2:113030158-113031322	PBDE	blood:	n/a	n/a
17	POLR2A	chr2:113030190-113030714	K562	blood:	n/a	n/a
18	MAZ	chr2:113030163-113031058	K562	blood:	n/a	n/a

No data

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr14:65875763..65877447-chr2:113029987..113031986,2	MCF-7	breast:
2	chr2:113010163..113016150-chr2:113027955..113035093,25	K562	blood:

No data

Variant related genes	Relation type
ZC3H6	TF binding region
ENSG00000238951	TF binding region
ENSG00000033170	Chromatin interaction
ENSG00000144161	Chromatin interaction

Extended variants
information (count: 98 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:83)

rs_ID	r²[population]
rs10167090	0.82[AFR][1000 genomes];0.83[ASN][1000 genomes]
rs10169159	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs10175234	0.91[ASN][1000 genomes]
rs10177573	0.81[CHB][hapmap];0.94[JPT][hapmap];1.00[YRI][hapmap];0.97[AFR][1000 genomes];0.96[ASN][1000 genomes]
rs10183121	0.81[CHB][hapmap];0.82[JPT][hapmap];0.81[YRI][hapmap];0.88[ASN][1000 genomes]
rs10191002	0.87[CHB][hapmap];0.94[JPT][hapmap];1.00[YRI][hapmap];0.81[AFR][1000 genomes]
rs10196933	0.81[ASN][1000 genomes]
rs10203614	0.81[ASN][1000 genomes]
rs10203843	0.92[AFR][1000 genomes];0.81[ASN][1000 genomes]
rs10205038	0.87[CHB][hapmap];0.94[JPT][hapmap];0.94[ASN][1000 genomes]
rs10211300	0.88[JPT][hapmap]
rs10439391	0.82[CHB][hapmap];0.94[JPT][hapmap];0.81[ASN][1000 genomes]
rs10864903	0.82[CHB][hapmap];0.94[JPT][hapmap];1.00[YRI][hapmap];0.93[AFR][1000 genomes];0.81[ASN][1000 genomes]
rs11123131	0.82[ASN][1000 genomes]
rs11123132	0.83[ASN][1000 genomes]
rs11123135	0.81[ASN][1000 genomes]
rs11123136	0.82[AFR][1000 genomes]
rs11674953	0.87[CHB][hapmap];0.94[JPT][hapmap];0.92[ASN][1000 genomes]
rs11688418	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs11689487	0.99[ASN][1000 genomes]
rs11691431	0.87[CHB][hapmap];0.94[JPT][hapmap];0.94[ASN][1000 genomes]
rs11691794	0.99[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs11896500	0.92[AFR][1000 genomes]
rs11903741	0.87[CHB][hapmap];0.94[JPT][hapmap];1.00[YRI][hapmap];0.92[AFR][1000 genomes]
rs11904424	0.90[AFR][1000 genomes]
rs12464478	0.84[AFR][1000 genomes]
rs12620553	0.81[ASN][1000 genomes]
rs12711737	0.93[ASN][1000 genomes]
rs12711738	1.00[CEU][hapmap];0.87[CHB][hapmap];0.94[JPT][hapmap];1.00[YRI][hapmap];0.93[AFR][1000 genomes];0.99[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs12711739	0.82[CHB][hapmap];0.94[JPT][hapmap];1.00[YRI][hapmap]
rs13387611	0.87[CHB][hapmap];0.94[JPT][hapmap];1.00[YRI][hapmap];0.82[AFR][1000 genomes]
rs13407329	0.82[ASN][1000 genomes]
rs34471791	0.82[AFR][1000 genomes]
rs34623958	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs4258804	0.88[AFR][1000 genomes];0.81[ASN][1000 genomes]
rs4299347	0.87[CHB][hapmap];0.94[JPT][hapmap]
rs4332934	0.95[AFR][1000 genomes];0.81[ASN][1000 genomes]
rs4352239	0.82[CHB][hapmap];0.94[JPT][hapmap]
rs4392265	0.96[ASN][1000 genomes]
rs4399734	0.82[CHB][hapmap];0.94[JPT][hapmap];1.00[YRI][hapmap];0.87[AFR][1000 genomes]
rs4419238	0.81[ASN][1000 genomes]
rs4430968	0.87[CHB][hapmap];0.94[JPT][hapmap];1.00[YRI][hapmap];0.95[AFR][1000 genomes];0.81[ASN][1000 genomes]
rs4446076	0.96[ASN][1000 genomes]
rs4450606	0.82[CHB][hapmap];0.94[JPT][hapmap];1.00[YRI][hapmap];0.95[AFR][1000 genomes];0.81[ASN][1000 genomes]
rs4450607	0.84[AFR][1000 genomes]
rs4456711	0.82[CHB][hapmap];0.94[JPT][hapmap];1.00[YRI][hapmap];0.92[AFR][1000 genomes];0.81[ASN][1000 genomes]
rs4507112	0.82[CHB][hapmap];0.94[JPT][hapmap];1.00[YRI][hapmap];0.82[AFR][1000 genomes]
rs4522611	0.87[CHB][hapmap];0.94[JPT][hapmap];1.00[YRI][hapmap];0.87[AFR][1000 genomes]
rs4525706	0.82[CHB][hapmap];0.94[JPT][hapmap];1.00[YRI][hapmap];0.82[AFR][1000 genomes]
rs4539797	0.95[AFR][1000 genomes];0.81[ASN][1000 genomes]
rs4542853	0.87[CHB][hapmap];0.94[JPT][hapmap];0.81[ASN][1000 genomes]
rs4578863	0.87[CHB][hapmap];0.94[JPT][hapmap]
rs4622729	0.87[CHB][hapmap];0.94[JPT][hapmap];1.00[YRI][hapmap];0.87[AFR][1000 genomes]
rs4849056	0.87[ASN][1000 genomes]
rs4849057	0.92[ASN][1000 genomes]
rs58337061	0.92[AFR][1000 genomes];0.81[ASN][1000 genomes]
rs6542045	1.00[CEU][hapmap];0.87[CHB][hapmap];0.94[JPT][hapmap];1.00[YRI][hapmap];0.99[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs6542048	0.93[AFR][1000 genomes];0.98[AMR][1000 genomes];0.97[EUR][1000 genomes];0.95[ASN][1000 genomes]
rs6542050	0.97[AFR][1000 genomes];0.96[ASN][1000 genomes]
rs6542051	0.82[CHB][hapmap];0.94[JPT][hapmap];1.00[YRI][hapmap];0.93[AFR][1000 genomes];0.81[ASN][1000 genomes]
rs6542053	0.81[AFR][1000 genomes]
rs6708164	0.87[AFR][1000 genomes]
rs6716010	0.94[ASN][1000 genomes]
rs6725933	0.81[ASN][1000 genomes]
rs6733138	0.82[CHB][hapmap];0.94[JPT][hapmap];1.00[YRI][hapmap];0.82[AFR][1000 genomes]
rs6744364	0.82[AFR][1000 genomes]
rs6745942	0.94[AFR][1000 genomes];0.96[ASN][1000 genomes]
rs6751146	0.82[CHB][hapmap];0.94[JPT][hapmap];0.82[AFR][1000 genomes]
rs6758110	0.87[CHB][hapmap];0.94[JPT][hapmap];1.00[YRI][hapmap];0.82[AFR][1000 genomes]
rs6761599	0.86[CHB][hapmap];0.93[JPT][hapmap];1.00[YRI][hapmap];0.82[AFR][1000 genomes]
rs71414636	0.87[ASN][1000 genomes]
rs72831684	0.96[ASN][1000 genomes]
rs7557281	0.87[CHB][hapmap];0.94[JPT][hapmap];1.00[YRI][hapmap];0.95[AFR][1000 genomes];0.93[ASN][1000 genomes]
rs7557862	0.93[JPT][hapmap];0.82[AFR][1000 genomes]
rs7564052	0.89[AFR][1000 genomes];0.81[ASN][1000 genomes]
rs7569894	0.87[AFR][1000 genomes]
rs7571435	0.87[CHB][hapmap];0.94[JPT][hapmap];0.92[ASN][1000 genomes]
rs7591439	0.87[CHB][hapmap];0.94[JPT][hapmap];1.00[YRI][hapmap];0.82[AFR][1000 genomes]
rs7598168	0.82[CHB][hapmap];0.94[JPT][hapmap];1.00[YRI][hapmap];0.84[AFR][1000 genomes]
rs7599041	0.82[AFR][1000 genomes]
rs7600338	0.82[CHB][hapmap];0.94[JPT][hapmap];0.81[ASN][1000 genomes]
rs7601200	0.87[CHB][hapmap];0.94[JPT][hapmap]
rs7601888	0.89[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:15 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv874863	chr2:112591224-113157344	Weak transcription Active TSS Strong transcription Flanking Active TSS Enhancers Genic enhancers Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	57 gene(s)	inside rSNPs	diseases
2	nsv874864	chr2:112617280-113104142	Strong transcription Enhancers Genic enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Active TSS ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	57 gene(s)	inside rSNPs	diseases
3	nsv874865	chr2:112623098-113049274	Enhancers Genic enhancers Strong transcription Weak transcription ZNF genes & repeats Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	57 gene(s)	inside rSNPs	diseases
4	esv3422414	chr2:112883450-113200285	Strong transcription Weak transcription Bivalent Enhancer Enhancers ZNF genes & repeats Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	39 gene(s)	inside rSNPs	diseases
5	nsv582703	chr2:112920219-113100014	Weak transcription Flanking Active TSS Enhancers Active TSS Strong transcription ZNF genes & repeats Genic enhancers Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA	37 gene(s)	inside rSNPs	diseases
6	nsv874867	chr2:112930064-113038409	Flanking Active TSS Enhancers Strong transcription Active TSS Weak transcription ZNF genes & repeats Genic enhancers Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	37 gene(s)	inside rSNPs	diseases
7	esv1805614	chr2:112949713-113048705	Enhancers Flanking Active TSS Weak transcription Strong transcription Active TSS Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA	36 gene(s)	inside rSNPs	diseases
8	nsv949573	chr2:112986955-113320975	Strong transcription Active TSS Enhancers Weak transcription Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	48 gene(s)	inside rSNPs	diseases
9	nsv874868	chr2:113021811-113076095	Enhancers Flanking Active TSS Weak transcription ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers Active TSS Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA	33 gene(s)	inside rSNPs	diseases
10	nsv874869	chr2:113021811-113089267	Flanking Active TSS Weak transcription Active TSS Strong transcription Transcr. at gene 5' and 3' Enhancers ZNF genes & repeats Bivalent/Poised TSS Genic enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA	33 gene(s)	inside rSNPs	diseases
11	nsv874870	chr2:113021811-113097699	Enhancers Active TSS Flanking Active TSS Weak transcription Strong transcription ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA	33 gene(s)	inside rSNPs	diseases
12	nsv874871	chr2:113021811-113217630	Enhancers Weak transcription Active TSS Flanking Active TSS Strong transcription ZNF genes & repeats Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	34 gene(s)	inside rSNPs	diseases
13	nsv874872	chr2:113027569-113070889	Weak transcription Enhancers Strong transcription Transcr. at gene 5' and 3' Active TSS Flanking Active TSS ZNF genes & repeats Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA	33 gene(s)	inside rSNPs	diseases
14	nsv874873	chr2:113027569-113083367	Active TSS Weak transcription Flanking Active TSS Enhancers Strong transcription ZNF genes & repeats Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA	33 gene(s)	inside rSNPs	diseases
15	nsv874874	chr2:113027569-113089267	Active TSS Strong transcription Transcr. at gene 5' and 3' Weak transcription Enhancers Flanking Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Genic enhancers Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA	33 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:11 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:113025200-113032600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
2	chr2:113026400-113032200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
3	chr2:113026800-113032600	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
4	chr2:113029200-113031200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
5	chr2:113029400-113032200	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
6	chr2:113030000-113030400	Active TSS	K562	blood
7	chr2:113030000-113031600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
8	chr2:113030200-113030600	Enhancers	iPS-18 Cell Line	embryonic stem cell
9	chr2:113030200-113031400	Enhancers	ES-I3 Cell Line	embryonic stem cell
10	chr2:113030200-113031400	Enhancers	HUES6 Cell Line	embryonic stem cell
11	chr2:113030200-113032000	Weak transcription	HepG2	liver

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links